SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDVO.L Regulatory News (DVO)

  • There is currently no data for DVO

Interim Management Statement

14 Nov 2013 07:00

RNS Number : 9770S
Devro PLC
14 November 2013
 



For immediate release

14 November 2013

 

 

Devro plc

("the Group")

 

Interim Management Statement

 

Devro plc, one of the world's leading manufacturers of collagen products for the food industry, today provides an Interim Management Statement covering the period from 1 July 2013 to date.

 

Revenue continued to grow helped by the full impact of price increases implemented in the first half with sales volumes unchanged against the same period last year. Trading profits and margins have improved in the second half as new capacity at the Czech plant has come on stream.

Sales have been strong in emerging markets, most notably Latin America, China and South East Asia. Germany and Japan continued to grow volumes across all major product categories. Developed markets such as the UK, continental Europe, Australia and North America traded more slowly than prior year and below our expectations.

Select, the innovative thin walled casing introduced in 2010 to replace top quality sheep gut, continues to make a significant contribution to sales. In the year to date Select accounts for 8% of all sales in the Group. There continue to be good opportunities for new sales.

Manufacturing operations ran well with the investment at the Czech plant now complete and production at full capacity.

The Board has approved capital expenditure to construct a new manufacturing hall at our site in South Carolina, USA. This £40m project, which will be funded from the Group's existing facilities and future cash flow, will enable the business to reduce manufacturing costs by c.£8m pa from 2016 onwards, with full benefits expected in 2017. This investment is part of our continuing manufacturing improvement programme which will further enhance profits for sales into the Americas.

As mentioned at the interims, the Group is actively evaluating options for expansion of capacity through an investment in China and we expect to report on this in early 2014.

Hide prices are higher than the prior year although the rate of increase has significantly slowed compared with the increases experienced in the last 18 months.

The Japanese yen has devalued by 20% against prior year although the impact on 2013 has been minimised through forward hedging. In 2014, based on current exchange rates, we estimate that profits will be adversely affected by approximately £3m as current hedging arrangements unwind.

Gross debt is broadly in line with the level at the half year and continues to be well within the banking facilities.

 

Outlook

 

In light of unchanged sales volumes and weakness in some developed markets since 1st July, the Board now expects the outcome for 2013 to be towards the lower end of market expectations.

 

The Board remains confident in the longer term opportunities for supplying a dynamic and growing global market for edible casings.

 

For further information, please contact:

Devro plc

 

Peter Page, Chief Executive

Simon Webb, Group Finance Director

 

Tel No: 0207 182 4960

 

Buchanan

 

Charles Ryland / Sophie McNulty / Clare Akhurst

 

 

Tel No: 020 7466 5000

Further information on Devro can be found on the company's website: www.devro.com

As previously announced, Devro will be holding an investor presentation to provide an update on the Group's investment programme today at 4.00pm. The presentation will be available on the company's website shortly thereafter. No new material information will be disclosed during the presentation.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSZMMMMNFZGFZM
Date   Source Headline
4th Mar 20147:00 amRNSRESULTS FOR THE YEAR ENDED 31 DECEMBER 2013
24th Feb 20146:09 pmRNSHolding(s) in Company - Amendment
7th Feb 20143:54 pmRNSHolding(s) in Company
27th Jan 201411:06 amRNSHolding(s) in Company
24th Jan 20141:04 pmRNSHolding(s) in Company
31st Dec 201312:36 pmRNSDirector/PDMR Shareholding
28th Nov 20138:29 amRNSDirector/PDMR Shareholding
25th Nov 20132:13 pmRNSBlocklisting Interim Review
14th Nov 20137:00 amRNSInterim Management Statement
15th Oct 20139:28 amRNSNotification of IMS date and Capital Markets Event
27th Sep 20135:26 pmRNSHolding(s) in Company
12th Sep 20134:46 pmRNSDirector/PDMR Shareholding
30th Aug 201311:29 amRNSTotal Voting Rights
12th Aug 20135:12 pmRNSDirector/PDMR Shareholding
31st Jul 20137:00 amRNS2013 Interim Results
30th Jul 20137:00 amRNSAppointment of Non-Executive Director
22nd Jul 201311:21 amRNSBlocklisting Application
5th Jul 201312:57 pmRNSHolding(s) in Company
2nd Jul 201310:00 amRNSInterim Results Webcast Notification
24th Jun 20137:00 amRNSPre-close trading update
18th Jun 20134:27 pmRNSHolding(s) in Company
14th Jun 20139:30 amRNSNotification of Upcoming Updates
31st May 20135:00 pmRNSTotal Voting Rights
24th May 20135:00 pmRNSBlocklisting Six Monthly Return
13th May 20133:17 pmRNSDirector/PDMR Transaction
3rd May 20133:36 pmRNSDirector/PDMR Transaction
30th Apr 201312:47 pmRNSTotal Voting Rights
23rd Apr 20134:43 pmRNSDirectors Dealings
23rd Apr 20139:24 amRNSHolding(s) in Company
23rd Apr 20137:00 amRNSSite Visit
22nd Apr 201310:34 amRNSHolding(s) in Company
18th Apr 20135:21 pmRNSResults of Annual General Meeting
18th Apr 20137:00 amRNSIMS & AGM
11th Apr 20133:32 pmRNSHolding(s) in Company
5th Apr 20133:10 pmRNSBlocklisting Application
2nd Apr 20138:06 amRNSTotal Voting Rights
28th Mar 20132:43 pmRNSHolding(s) in Company
22nd Mar 20134:35 pmRNSHolding(s) in Company
19th Mar 20134:33 pmRNSDirector/PDMR Shareholding
15th Mar 20132:00 pmRNS2012 Annual Report
14th Mar 20135:10 pmRNSDirector/PDMR Shareholding
1st Mar 20133:48 pmRNSDirector/PDMR Shareholding
26th Feb 201311:44 amRNS2012 Final Dividend Record Date Amendment
26th Feb 20137:00 amRNSRESULTS FOR THE YEAR ENDED 31 DECEMBER 2012
14th Jan 201312:29 pmRNSListing Rule 9.6.14(R) Disclosure
8th Jan 20132:25 pmRNSPreliminary Results Notification
21st Dec 20122:22 pmRNSAnnual Information Update
19th Dec 20125:31 pmRNSDirector/PDMR Shareholding
18th Dec 20128:59 amRNSListing Rule 9.6.14(R) Disclosure
23rd Nov 20128:53 amRNSBlocklisting Six Monthly Return

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.